- Advertise
- Contact Editorial
- Editorial Submission Guidelines
- Contact MJH Life Sciences
- Do Not Sell My Personal Information
- Privacy Policy
- Terms and Conditions
© 2023 MJH Life Sciences™ and Pharmaceutical Executive. All rights reserved.
Pharmaceutical Executive-09-01-2011
Pharmaceutical Executive
Pharmaceutical Executive Digital Edition - September 2011
September 01, 2011
Issue PDF
0
0
From Many, One
Pharm Exec's 10th Annual Industry Audit
September 01, 2011
Features
0
0
Bill Trombetta surveys the landscape of pharma financials over the past year, and shows which companies rode the wave to the top of the industry in delivering value to shareholders.
Bridging the Hidden Hurdle in Cancer Cures
September 01, 2011
Columns
0
0
Diagnostics can bost the efficacy of drug treatments, but delivering the promise depends on a predictible pathway to reimbursement.
Pharma and Social Media: Ready to Make Nice?
September 01, 2011
Features
0
0
The time is right for industry to overcome its social media phobia once and for all.
The Power of Product Development Partnership
September 01, 2011
Features
0
0
Can cooperative ties between Big Pharma, NGOs, government, and international organizations pay the freight in making the fight against neglected diseases a permanent fix in global health?
Front and Center in the Fight against TB
September 01, 2011
Features
0
0
Pharm Exec talks to Dr. Mel Spigelman, President and CEO of the TB Alliance, about the organization's tuberculosis priorities.
How to Recruit 70,000 People in One Year
September 01, 2011
0
0
Tata Consultancy Services has grown into one of the largest IT solutions providers in the world
Innovating Around Innovation
September 01, 2011
Columns
0
0
Richard Barker, former Director General of ABPI, proposes a new agenda on how to restore public confidence in the value behind science.
India: Good Endings, Good Beginnings!
September 01, 2011
0
0
Within an industry that traditionally moves at a slow pace, the rapidly changing playing field as required both Indian pharmaceutical companies, as well as MNCs, to adjust their strategies accordingly
Two Million Man Hours
September 01, 2011
0
0
PricewaterhouseCooper's "Global Construction 2020" report predictions
Rebates and Reform
September 01, 2011
Columns
0
0
User-fee renewal legislation sets the stage for new policies affecting reimbursement, research, and regulatory oversight.
Should the US Gamble with Risk Sharing?
September 01, 2011
Features
0
0
Especially when payers come to the table holding the best cards - leaving industry second-guessing its strategy.
The Power of Observation
September 01, 2011
Columns
0
0
Observational studies present a compelling real-world corollary to the classic randomized clinical trial.
Get Back in the Box!
September 01, 2011
From the Editor
0
0
Despite the gloom, most forecasts show the US will stay atop the industry in profits for at least the next generation of products.
Turning the Ins and Outs of Marketing Inside-Out
September 01, 2011
Columns
0
0
Keeping your finger on the pulse of consumers leads to better, more actionable insights-and better results.
The Capital of the Future
September 01, 2011
0
0
Gujarati has become one of India's most industrialized states